Loading…

Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil

To develop and validate a nomogram to estimate the probability of prostate cancer (PCa) in men undergoing opportunistic screening. This was a cross-sectional observational study on a cohort of men screened for PCa at the Barretos Cancer Hospital (BCH) between January 2004 and December 2007. Patients...

Full description

Saved in:

Bibliographic Details
Published in:	Anticancer research 2015-05, Vol.35 (5), p.2881-2886
Main Authors:	Silva, Thiago B, Oliveira, Cleyton Z, Faria, Eliney F, Mauad, Edmundo C, Syrjänen, Kari J, Carvalho, André L
Format:	Article
Language:	English
Subjects:	Aged Biopsy Brazil Cross-Sectional Studies Humans Male Middle Aged Nomograms Prognosis Prostate-Specific Antigen - blood Prostatic Neoplasms - epidemiology Prostatic Neoplasms - pathology ROC Curve
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	2886
container_issue	5
container_start_page	2881
container_title	Anticancer research
container_volume	35
creator	Silva, Thiago B Oliveira, Cleyton Z Faria, Eliney F Mauad, Edmundo C Syrjänen, Kari J Carvalho, André L
description	To develop and validate a nomogram to estimate the probability of prostate cancer (PCa) in men undergoing opportunistic screening. This was a cross-sectional observational study on a cohort of men screened for PCa at the Barretos Cancer Hospital (BCH) between January 2004 and December 2007. Patients' data were collected from their charts and binary logistic regression analyses were performed to assess the power of various factor combinations as predictors of the PCa risk. Out of the 1,313 screened men who underwent prostate biopsy, 553 (42.1%) had histopathological confirmation of PCa. The logistic regression analyses provided an area under the receiver operating characteristics (ROC) curve (AUC) of 0.737 (95% confidence interval (CI)=0.678-0.796) for the best predictor combination. A nomogram was constructed to estimate the individual risk for PCa prior to biopsy. Our nomogram provides an easy and practical method, superior in performance to the traditional criteria, predicting the diagnosis of PCa with a reasonable accuracy.
format	article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680753232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1680753232</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-30b448837087d0c67356623b04eb2e6f0b624ac69fdac32ed2f64edc4c73b8fc3</originalsourceid><addsrcrecordid>eNo1UEtLxDAYDIK4a_UvSI5eCnk1aY-6PmHBi168lDT5qtE2qUm6oL_eLq7MYWAYhpk5QmuqGlqqipMVOk3pgxApm5qfoBWrGikqRdfo9QZ2MIRpBJ-x9hbv9OCszi54HHqssQ9jeIt6xDlgSNmNOgPO74CjS597yxRDynvRaG8gYufxddQ_bjhDx70eEpwfuEAvd7fPm4dy-3T_uLnalhOjNJecdELUNVekVpYYqXglJeMdEdAxkD3pJBPayKa32nAGlvVSgDXCKN7VveEFuvzLXZp8zUvHdnTJwDBoD2FOLZU1WU5gCwp0cbDO3Qi2neKyJ363_3_wX25eW5U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680753232</pqid></control><display><type>article</type><title>Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil</title><source>EZB Electronic Journals Library</source><creator>Silva, Thiago B ; Oliveira, Cleyton Z ; Faria, Eliney F ; Mauad, Edmundo C ; Syrjänen, Kari J ; Carvalho, André L</creator><creatorcontrib>Silva, Thiago B ; Oliveira, Cleyton Z ; Faria, Eliney F ; Mauad, Edmundo C ; Syrjänen, Kari J ; Carvalho, André L</creatorcontrib><description>To develop and validate a nomogram to estimate the probability of prostate cancer (PCa) in men undergoing opportunistic screening. This was a cross-sectional observational study on a cohort of men screened for PCa at the Barretos Cancer Hospital (BCH) between January 2004 and December 2007. Patients' data were collected from their charts and binary logistic regression analyses were performed to assess the power of various factor combinations as predictors of the PCa risk. Out of the 1,313 screened men who underwent prostate biopsy, 553 (42.1%) had histopathological confirmation of PCa. The logistic regression analyses provided an area under the receiver operating characteristics (ROC) curve (AUC) of 0.737 (95% confidence interval (CI)=0.678-0.796) for the best predictor combination. A nomogram was constructed to estimate the individual risk for PCa prior to biopsy. Our nomogram provides an easy and practical method, superior in performance to the traditional criteria, predicting the diagnosis of PCa with a reasonable accuracy.</description><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 25964571</identifier><language>eng</language><publisher>Greece</publisher><subject>Aged ; Biopsy ; Brazil ; Cross-Sectional Studies ; Humans ; Male ; Middle Aged ; Nomograms ; Prognosis ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - epidemiology ; Prostatic Neoplasms - pathology ; ROC Curve</subject><ispartof>Anticancer research, 2015-05, Vol.35 (5), p.2881-2886</ispartof><rights>Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25964571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silva, Thiago B</creatorcontrib><creatorcontrib>Oliveira, Cleyton Z</creatorcontrib><creatorcontrib>Faria, Eliney F</creatorcontrib><creatorcontrib>Mauad, Edmundo C</creatorcontrib><creatorcontrib>Syrjänen, Kari J</creatorcontrib><creatorcontrib>Carvalho, André L</creatorcontrib><title>Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>To develop and validate a nomogram to estimate the probability of prostate cancer (PCa) in men undergoing opportunistic screening. This was a cross-sectional observational study on a cohort of men screened for PCa at the Barretos Cancer Hospital (BCH) between January 2004 and December 2007. Patients' data were collected from their charts and binary logistic regression analyses were performed to assess the power of various factor combinations as predictors of the PCa risk. Out of the 1,313 screened men who underwent prostate biopsy, 553 (42.1%) had histopathological confirmation of PCa. The logistic regression analyses provided an area under the receiver operating characteristics (ROC) curve (AUC) of 0.737 (95% confidence interval (CI)=0.678-0.796) for the best predictor combination. A nomogram was constructed to estimate the individual risk for PCa prior to biopsy. Our nomogram provides an easy and practical method, superior in performance to the traditional criteria, predicting the diagnosis of PCa with a reasonable accuracy.</description><subject>Aged</subject><subject>Biopsy</subject><subject>Brazil</subject><subject>Cross-Sectional Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nomograms</subject><subject>Prognosis</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - epidemiology</subject><subject>Prostatic Neoplasms - pathology</subject><subject>ROC Curve</subject><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNo1UEtLxDAYDIK4a_UvSI5eCnk1aY-6PmHBi168lDT5qtE2qUm6oL_eLq7MYWAYhpk5QmuqGlqqipMVOk3pgxApm5qfoBWrGikqRdfo9QZ2MIRpBJ-x9hbv9OCszi54HHqssQ9jeIt6xDlgSNmNOgPO74CjS597yxRDynvRaG8gYufxddQ_bjhDx70eEpwfuEAvd7fPm4dy-3T_uLnalhOjNJecdELUNVekVpYYqXglJeMdEdAxkD3pJBPayKa32nAGlvVSgDXCKN7VveEFuvzLXZp8zUvHdnTJwDBoD2FOLZU1WU5gCwp0cbDO3Qi2neKyJ363_3_wX25eW5U</recordid><startdate>201505</startdate><enddate>201505</enddate><creator>Silva, Thiago B</creator><creator>Oliveira, Cleyton Z</creator><creator>Faria, Eliney F</creator><creator>Mauad, Edmundo C</creator><creator>Syrjänen, Kari J</creator><creator>Carvalho, André L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201505</creationdate><title>Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil</title><author>Silva, Thiago B ; Oliveira, Cleyton Z ; Faria, Eliney F ; Mauad, Edmundo C ; Syrjänen, Kari J ; Carvalho, André L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-30b448837087d0c67356623b04eb2e6f0b624ac69fdac32ed2f64edc4c73b8fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Biopsy</topic><topic>Brazil</topic><topic>Cross-Sectional Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nomograms</topic><topic>Prognosis</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - epidemiology</topic><topic>Prostatic Neoplasms - pathology</topic><topic>ROC Curve</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, Thiago B</creatorcontrib><creatorcontrib>Oliveira, Cleyton Z</creatorcontrib><creatorcontrib>Faria, Eliney F</creatorcontrib><creatorcontrib>Mauad, Edmundo C</creatorcontrib><creatorcontrib>Syrjänen, Kari J</creatorcontrib><creatorcontrib>Carvalho, André L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, Thiago B</au><au>Oliveira, Cleyton Z</au><au>Faria, Eliney F</au><au>Mauad, Edmundo C</au><au>Syrjänen, Kari J</au><au>Carvalho, André L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2015-05</date><risdate>2015</risdate><volume>35</volume><issue>5</issue><spage>2881</spage><epage>2886</epage><pages>2881-2886</pages><eissn>1791-7530</eissn><abstract>To develop and validate a nomogram to estimate the probability of prostate cancer (PCa) in men undergoing opportunistic screening. This was a cross-sectional observational study on a cohort of men screened for PCa at the Barretos Cancer Hospital (BCH) between January 2004 and December 2007. Patients' data were collected from their charts and binary logistic regression analyses were performed to assess the power of various factor combinations as predictors of the PCa risk. Out of the 1,313 screened men who underwent prostate biopsy, 553 (42.1%) had histopathological confirmation of PCa. The logistic regression analyses provided an area under the receiver operating characteristics (ROC) curve (AUC) of 0.737 (95% confidence interval (CI)=0.678-0.796) for the best predictor combination. A nomogram was constructed to estimate the individual risk for PCa prior to biopsy. Our nomogram provides an easy and practical method, superior in performance to the traditional criteria, predicting the diagnosis of PCa with a reasonable accuracy.</abstract><cop>Greece</cop><pmid>25964571</pmid><tpages>6</tpages></addata></record>
fulltext	fulltext
identifier	EISSN: 1791-7530
ispartof	Anticancer research, 2015-05, Vol.35 (5), p.2881-2886
issn	1791-7530
language	eng
recordid	cdi_proquest_miscellaneous_1680753232
source	EZB Electronic Journals Library
subjects	Aged Biopsy Brazil Cross-Sectional Studies Humans Male Middle Aged Nomograms Prognosis Prostate-Specific Antigen - blood Prostatic Neoplasms - epidemiology Prostatic Neoplasms - pathology ROC Curve
title	Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A24%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20nomogram%20to%20estimate%20the%20risk%20of%20prostate%20cancer%20in%20Brazil&rft.jtitle=Anticancer%20research&rft.au=Silva,%20Thiago%20B&rft.date=2015-05&rft.volume=35&rft.issue=5&rft.spage=2881&rft.epage=2886&rft.pages=2881-2886&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1680753232%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p211t-30b448837087d0c67356623b04eb2e6f0b624ac69fdac32ed2f64edc4c73b8fc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1680753232&rft_id=info:pmid/25964571&rfr_iscdi=true